Global Metastatic Bone Disease Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1699

Metastatic bone disease treatments are treatment options of MBD which is a kind of cancer that begins in an organ, such as the lungs, breast, or prostate, and then spreads to bone.
In 2018, the global Metastatic Bone Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metastatic Bone Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metastatic Bone Disease Treatment development in United States, Europe and China.

The key players covered in this study
Merck & Co.
Eli Lilly and Company
F. Hoffmann-La Roche
Amgen
Novartis
Bayer
BTG
Fresenius Kabi
Medtronic
Boston Scientific Corporation

Market segment by Type, the product can be split into
Medication
Radiation Therapy
Surgical Intervention
Tumor Ablation Therapy

Market segment by Application, split into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metastatic Bone Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Metastatic Bone Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metastatic Bone Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metastatic Bone Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Medication
1.4.3 Radiation Therapy
1.4.4 Surgical Intervention
1.4.5 Tumor Ablation Therapy
1.5 Market by Application
1.5.1 Global Metastatic Bone Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metastatic Bone Disease Treatment Market Size
2.2 Metastatic Bone Disease Treatment Growth Trends by Regions
2.2.1 Metastatic Bone Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Metastatic Bone Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Metastatic Bone Disease Treatment Market Size by Manufacturers
3.1.1 Global Metastatic Bone Disease Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Metastatic Bone Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metastatic Bone Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Metastatic Bone Disease Treatment Key Players Head office and Area Served
3.3 Key Players Metastatic Bone Disease Treatment Product/Solution/Service
3.4 Date of Enter into Metastatic Bone Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metastatic Bone Disease Treatment Market Size by Type (2014-2019)
4.2 Global Metastatic Bone Disease Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Metastatic Bone Disease Treatment Market Size (2014-2019)
5.2 Metastatic Bone Disease Treatment Key Players in United States
5.3 United States Metastatic Bone Disease Treatment Market Size by Type
5.4 United States Metastatic Bone Disease Treatment Market Size by Application

6 Europe
6.1 Europe Metastatic Bone Disease Treatment Market Size (2014-2019)
6.2 Metastatic Bone Disease Treatment Key Players in Europe
6.3 Europe Metastatic Bone Disease Treatment Market Size by Type
6.4 Europe Metastatic Bone Disease Treatment Market Size by Application

7 China
7.1 China Metastatic Bone Disease Treatment Market Size (2014-2019)
7.2 Metastatic Bone Disease Treatment Key Players in China
7.3 China Metastatic Bone Disease Treatment Market Size by Type
7.4 China Metastatic Bone Disease Treatment Market Size by Application

8 Japan
8.1 Japan Metastatic Bone Disease Treatment Market Size (2014-2019)
8.2 Metastatic Bone Disease Treatment Key Players in Japan
8.3 Japan Metastatic Bone Disease Treatment Market Size by Type
8.4 Japan Metastatic Bone Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metastatic Bone Disease Treatment Market Size (2014-2019)
9.2 Metastatic Bone Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Metastatic Bone Disease Treatment Market Size by Type
9.4 Southeast Asia Metastatic Bone Disease Treatment Market Size by Application

10 India
10.1 India Metastatic Bone Disease Treatment Market Size (2014-2019)
10.2 Metastatic Bone Disease Treatment Key Players in India
10.3 India Metastatic Bone Disease Treatment Market Size by Type
10.4 India Metastatic Bone Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Metastatic Bone Disease Treatment Market Size (2014-2019)
11.2 Metastatic Bone Disease Treatment Key Players in Central & South America
11.3 Central & South America Metastatic Bone Disease Treatment Market Size by Type
11.4 Central & South America Metastatic Bone Disease Treatment Market Size by Application

12 International Players Profiles
12.1 Merck & Co.
12.1.1 Merck & Co. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metastatic Bone Disease Treatment Introduction
12.1.4 Merck & Co. Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.1.5 Merck & Co. Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metastatic Bone Disease Treatment Introduction
12.2.4 Eli Lilly and Company Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.2.5 Eli Lilly and Company Recent Development
12.3 F. Hoffmann-La Roche
12.3.1 F. Hoffmann-La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metastatic Bone Disease Treatment Introduction
12.3.4 F. Hoffmann-La Roche Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metastatic Bone Disease Treatment Introduction
12.4.4 Amgen Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metastatic Bone Disease Treatment Introduction
12.5.4 Novartis Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metastatic Bone Disease Treatment Introduction
12.6.4 Bayer Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 BTG
12.7.1 BTG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metastatic Bone Disease Treatment Introduction
12.7.4 BTG Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.7.5 BTG Recent Development
12.8 Fresenius Kabi
12.8.1 Fresenius Kabi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metastatic Bone Disease Treatment Introduction
12.8.4 Fresenius Kabi Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.8.5 Fresenius Kabi Recent Development
12.9 Medtronic
12.9.1 Medtronic Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metastatic Bone Disease Treatment Introduction
12.9.4 Medtronic Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.9.5 Medtronic Recent Development
12.10 Boston Scientific Corporation
12.10.1 Boston Scientific Corporation Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metastatic Bone Disease Treatment Introduction
12.10.4 Boston Scientific Corporation Revenue in Metastatic Bone Disease Treatment Business (2014-2019)
12.10.5 Boston Scientific Corporation Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details